252 related articles for article (PubMed ID: 24727996)
1. The evolution of clinical trials for infant acute lymphoblastic leukemia.
Kotecha RS; Gottardo NG; Kees UR; Cole CH
Blood Cancer J; 2014 Apr; 4(4):e200. PubMed ID: 24727996
[TBL] [Abstract][Full Text] [Related]
2. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
3. Outcome of recurrent or refractory acute lymphoblastic leukemia in infants with MLL gene rearrangements: A report from the Japan Infant Leukemia Study Group.
Tomizawa D; Koh K; Hirayama M; Miyamura T; Hatanaka M; Saikawa Y; Ishii E
Pediatr Blood Cancer; 2009 Jul; 52(7):808-13. PubMed ID: 19229974
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
[TBL] [Abstract][Full Text] [Related]
5. FLAG/FLAG-IDA regimen for children with relapsed/refractory acute leukemia in the era of targeted novel therapies.
Mustafa O; Abdalla K; AlAzmi AA; Elimam N; Abrar MB; Jastaniah W
J Oncol Pharm Pract; 2019 Dec; 25(8):1831-1838. PubMed ID: 30518307
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors and treatment of pediatric acute lymphoblastic leukemia.
Lee JW; Cho B
Korean J Pediatr; 2017 May; 60(5):129-137. PubMed ID: 28592975
[TBL] [Abstract][Full Text] [Related]
7. Acute lymphoblastic leukemia in children: current status, controversies, and future perspective.
Miller LP; Miller DR
Crit Rev Oncol Hematol; 1983; 1(2):129-97. PubMed ID: 6397264
[TBL] [Abstract][Full Text] [Related]
8. Survival outcome following isolated central nervous system relapse treated with additional chemotherapy and craniospinal irradiation in childhood acute lymphoblastic leukemia.
Kumar P; Kun LE; Hustu HO; Mulhern RK; Hancock ML; Coffey D; Rivera GK
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):477-83. PubMed ID: 7852109
[TBL] [Abstract][Full Text] [Related]
9. Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies.
Uderzo C; Dini G; Locatelli F; Miniero R; Tamaro P
Haematologica; 2000 Nov; 85(11 Suppl):47-53. PubMed ID: 11268324
[TBL] [Abstract][Full Text] [Related]
10. A systematic overview of chemotherapy effects in acute myeloid leukaemia.
Kimby E; Nygren P; Glimelius B;
Acta Oncol; 2001; 40(2-3):231-52. PubMed ID: 11441935
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcome in children with relapsed acute lymphoblastic leukemia after time-point and site-of-relapse stratification and intensified short-course multidrug chemotherapy: results of trial ALL-REZ BFM 90.
Tallen G; Ratei R; Mann G; Kaspers G; Niggli F; Karachunsky A; Ebell W; Escherich G; Schrappe M; Klingebiel T; Fengler R; Henze G; von Stackelberg A
J Clin Oncol; 2010 May; 28(14):2339-47. PubMed ID: 20385996
[TBL] [Abstract][Full Text] [Related]
12. Long-term results of NOPHO ALL-92 and ALL-2000 studies of childhood acute lymphoblastic leukemia.
Schmiegelow K; Forestier E; Hellebostad M; Heyman M; Kristinsson J; Söderhäll S; Taskinen M;
Leukemia; 2010 Feb; 24(2):345-54. PubMed ID: 20010622
[TBL] [Abstract][Full Text] [Related]
13. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
14. [Infant acute leukemia].
Brethon B; Cavé H; Fahd M; Baruchel A
Bull Cancer; 2016 Mar; 103(3):299-311. PubMed ID: 26826739
[TBL] [Abstract][Full Text] [Related]
15. Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia.
Dördelmann M; Reiter A; Borkhardt A; Ludwig WD; Götz N; Viehmann S; Gadner H; Riehm H; Schrappe M
Blood; 1999 Aug; 94(4):1209-17. PubMed ID: 10438708
[TBL] [Abstract][Full Text] [Related]
16. Adult acute leukemia.
Cripe LD
Curr Probl Cancer; 1997; 21(1):1-64. PubMed ID: 9058027
[TBL] [Abstract][Full Text] [Related]
17. Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group.
Reaman GH; Sposto R; Sensel MG; Lange BJ; Feusner JH; Heerema NA; Leonard M; Holmes EJ; Sather HN; Pendergrass TW; Johnstone HS; O'Brien RT; Steinherz PG; Zeltzer PM; Gaynon PS; Trigg ME; Uckun FM
J Clin Oncol; 1999 Feb; 17(2):445-55. PubMed ID: 10080584
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Münster Group 87.
Einsiedel HG; von Stackelberg A; Hartmann R; Fengler R; Schrappe M; Janka-Schaub G; Mann G; Hählen K; Göbel U; Klingebiel T; Ludwig WD; Henze G
J Clin Oncol; 2005 Nov; 23(31):7942-50. PubMed ID: 16258094
[TBL] [Abstract][Full Text] [Related]
19. Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium study.
Ko RH; Ji L; Barnette P; Bostrom B; Hutchinson R; Raetz E; Seibel NL; Twist CJ; Eckroth E; Sposto R; Gaynon PS; Loh ML
J Clin Oncol; 2010 Feb; 28(4):648-54. PubMed ID: 19841326
[TBL] [Abstract][Full Text] [Related]
20. Improved survival of infants less than 1 year of age with acute lymphoblastic leukemia treated with intensive multiagent chemotherapy.
Reaman GH; Steinherz PG; Gaynon PS; Bleyer WA; Finklestein JZ; Evans R; Miller DR; Sather HN; Hammond GD
Cancer Treat Rep; 1987 Nov; 71(11):1033-8. PubMed ID: 3315194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
